On December 18, SIPAI HEALTH (00314) spent 359,500 Hong Kong dollars to repurchase 150,800 shares.
SPT Health (00314) announced that on December 18, 2025, the company spent HK$359,500 to repurchase 150,800 shares at a repurchase price of HK$2.36-2.44 per share. On the same day, 2,000 shares were issued according to the revised and restated 2017 Global Equity Incentive Plan by exercising options.
SIPAI HEALTH (00314) announced that on December 18, 2025, the company repurchased 150,800 shares at a cost of 359,500 Hong Kong dollars, with a repurchase price of 2.36-2.44 Hong Kong dollars per share. On the same day, 2000 shares were issued in accordance with the revised and restated 2017 Global Share Plan exercising options.
Related Articles
US Stock Market Move | AI application software stocks rise, Applovin (APP.US) up more than 6%
US Stock Market Move | Orforglipron's oral weight-loss drug program achieves success in Phase III trial, causing Eli Lilly (LLY.US) stock to rise more than 3%.
US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rose more than 3%. Morgan Stanley predicts that the company's gross profit margin will surpass 60% in the fourth quarter.
US Stock Market Move | AI application software stocks rise, Applovin (APP.US) up more than 6%
US Stock Market Move | Orforglipron's oral weight-loss drug program achieves success in Phase III trial, causing Eli Lilly (LLY.US) stock to rise more than 3%.
US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rose more than 3%. Morgan Stanley predicts that the company's gross profit margin will surpass 60% in the fourth quarter.
